Crescent to Buy Healthscope's Australian Pathology Operations for A$105M
June 24, 2015
Crescent Capital Partners has agreed to acquire the Australian Pathology operations of Healthscope (ASX: HSO) for A$105 million ($81 million). As part of the deal, which is expected to close by the end of the July, Healthscope will also transfer six skin clinics from its Medical Centre operations to Crescent. The Australian Pathology operations consist of roughly 550 collection centers and 31 pathology laboratories.